The pulmonary fibrosis treatment market could grow from $1.3 billion to $2.7 billion by 2035 as newer therapies aim to ...

Care for patients with cystic fibrosis has undergone transformative changes over the past decade and serves as an example of how an understanding of the functional consequences of a genetic disease ...

Discover how FGFR2 hypermethylation drives kidney fibrosis in ageing and what it means for future CKD treatments.

The human liver carries out a wealth of vital functions through highly coordinated processes involving multiple cell types. However, when the liver is damaged by pharmaceuticals, cholestasis or ...

Fibrosis occurs when permanent scar tissue forms during wound healing and can strike almost any of the body’s tissues and organs with devastating consequences. In fact, statistics show that it ...

ALBUQUERQUE, N.M. (KRQE) – A flaw in the system may be dangerous for people with Cystic Fibrosis. Cystic Fibrosis is when a mutation creates mucus in the lungs, making it hard to breath. Thirty ...

NEW ORLEANS--(BUSINESS WIRE)-- FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), ...

Protein misfolding is a likely culprit in many degenerative disorders. Cystic fibrosis, for instance, is caused by mutations in the CFTR gene that prevent the eponymous protein from assuming its ...

Liver fibrosis is characterized by the excessive deposition of extracellular matrix, a process primarily driven by activated hepatic stellate cells ...